BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, December 5, 2025
Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 28, 2015

View Archived Issues

Shire reports pipeline progress of third quarter 2015

Read More

ClearPath Development launches NVC to develop vaccines against nosocomial bacterial infections

Read More

Hamni Science discloses cannabinoid CB1 receptor antagonists

Read More

SciVac Therapeutics plans to acquire VBI Vaccines

Read More

Roche and ETHZ report new cannabinoid CB2 receptor agonists

Read More

SiteOne and Stanford report sodium channel blockers for the treatment of pain

Read More

Small-molecule Dvl-CXXC5 antagonists show potential for the treatment of osteoporosis

Read More

ONO-8539: a new inhibitor of EP1 that reduces heartburn symptoms

Read More

Corvus Pharmaceuticals enters into trial collaboration with Genentech

Read More

4-Epi-isofagomine analogue shows promise for GM1-gangliosidosis and morquio syndrome type B

Read More

FDA approves Belbuca buccal film for chronic pain

Read More

Vertex and CRISPR Therapeutics establish research collaboration

Read More

MedImmune patents cytotoxic agents

Read More

Medshine Discovery patent details PARP-1 inhibitors

Read More

Shionogi divulges BACE1 inhibitors

Read More

Initial observations from phase II study of ganaxolone in PCDH19 female pediatric epilepsy

Read More

Therapeutic value of KML-29 in ALS and PD mice models

Read More

Hearing loss reduction with SENS-90 in severe noise model leads to clinical development

Read More

Japan's MHLW grants Sakigake designation to six drugs

Read More

Symic Biomedical advances SB-030 into clinical development

Read More

OPUS-3 trial of lifitegrast meets primary and key secondary endpoints for dry eye

Read More

Investigators report a novel mutation associated with Jalili syndrome

Read More

FDA approves Imlygic as first oncolytic viral therapy in U.S.

Read More

New derivative shows advantages over bumetanide as an anticonvulsant

Read More

Two phase III trials of Sativex in cancer pain report results

Read More

Allergan licenses rights to IBS-C therapy linaclotide from Almirall

Read More

Yakult Honsha licenses NIP-022 from Nissan Chemical

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 4, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 4, 2025.
  • Green molecules

    UK Biobank delivers largest metabolomics dataset of 500K profiles

    BioWorld Science
    It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
  • 3D rendering of prion structure

    Epigenetic technology could eliminate misfolded prion proteins

    BioWorld Science
    The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
  • Mesothelin is biomarker, potential target in arthritic bone damage

    BioWorld Science
    In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing